Understanding the cellular responses to anti‐Abeta antibodies to gain insights into mechanisms of ARIA
Kate E Foley, Erica M Weekman, Donna M Wilcock · 2025
Read Understanding the cellular responses to anti‐Abeta antibodies to gain insights into mechanisms of ARIA by Kate E Foley, Erica M Weekman, Donna M Wilcock (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709749.txt.
Description
Kate Foley, Erica Weekman, and Donna Wilcock probe why Alzheimer's antibody drugs sometimes injure blood vessels in the brain. Their 2025 paper concerns the first approved disease-modifying antibodies, which clear amyloid and slow decline. Their main side effect, ARIA, shows up as brain swelling or small bleeds on scans, and it blocks treatment for patients with heavy vessel disease.
Carriers of the APOE4 gene variant face the highest risk, with up to forty percent of double carriers affected. Using mouse models, the team gave antibodies systemically and directly into the brain. Immune cells called microglia switched on along amyloid-laden vessels, near the spots where microbleeds appeared. The work links vessel amyloid, immune activation, and the side effect.
Catalog record
| CREATOR | Kate E Foley, Erica M Weekman, Donna M Wilcock |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |